.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Cerilliant
Mallinckrodt
Cipla
Argus Health
Fish and Richardson
Covington
Johnson and Johnson
QuintilesIMS

Generated: December 13, 2017

DrugPatentWatch Database Preview

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Buprenorphine Hydrochloride And Naloxone Hydrochloride patents expire, and when can generic versions of Buprenorphine Hydrochloride And Naloxone Hydrochloride launch?

Buprenorphine Hydrochloride And Naloxone Hydrochloride is a drug marketed by Actavis Elizabeth, Amneal Pharms, Ethypharm Usa Corp, Kremers Urban Pharms, Sun Pharm Inds Ltd, Teva Pharms Usa, and West-ward Pharms Int. and is included in seven NDAs.

The generic ingredient in BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE is buprenorphine hydrochloride; naloxone hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.

Summary for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Drug patent expirations by year for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Pharmacology for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actavis ElizabethBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL091422-001Feb 22, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kremers Urban PharmsBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL205022-002Sep 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ethypharm Usa CorpBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL204431-001Oct 16, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL203326-002Jun 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL201633-002Aug 5, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE buprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL201633-001Aug 5, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL091422-002Feb 22, 2013ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL203136-002Feb 22, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kremers Urban PharmsBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL205022-001Sep 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ethypharm Usa CorpBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEbuprenorphine hydrochloride; naloxone hydrochlorideTABLET;SUBLINGUAL204431-002Oct 16, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Farmers Insurance
Chubb
Harvard Business School
Deloitte
Julphar
Argus Health
Cantor Fitzgerald
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot